LOVELAND, Colo., Jan. 31, 2022 /PRNewswire/ -- Heska Corporation (NASDAQ: HSKA; "Heska" or the "Company"), a leading global provider of advanced veterinary diagnostic and specialty products and solutions, will report its fourth quarter and full year 2021 financial performance in a press release before the market opens on Monday, February 28, 2022. The Company will also host an earnings call at 9 a.m. MT / 11 a.m. ET to discuss the results.
To access the conference call:
From within the United States, please dial 1-800-239-9838
From outside of the United States, please dial 1-323-794-2551
Reference Conference ID: 3732352
The earnings call will be webcast live from the Company's investor relations website at Heska Fourth Quarter and Full Year 2021 Earnings Call Webcast.
A telephonic replay will be available at 2 p.m. ET on February 28 through 11:59 p.m. ET on March 14, 2022 and the webcast will be archived on the Company's website for 90 days.
To access the replay:
From within the United States, please dial 1-844-512-2921
From outside the United States, please dial 1-412-317-6671
Reference Replay Pin Number: 3732352
About Heska
Heska Corporation (NASDAQ: HSKA) manufactures, develops and sells advanced veterinary diagnostic and specialty healthcare products through its two business segments: North America and International. Both segments include Point of Care Lab testing instruments and consumables, digital imaging products, software and services, data services, allergy testing and immunotherapy, and single-use offerings such as in-clinic diagnostic tests and heartworm preventive products. The North America segment also includes private label vaccine and pharmaceutical production under third-party agreements and channels, primarily for herd animal health. For more information, please visit www.heska.com.
SOURCE Heska Corporation
![](https://rt.prnewswire.com/rt.gif?NewsItemId=LA46007&Transmission_Id=202201310800PR_NEWS_USPR_____LA46007&DateId=20220131)
Share this article